[ad_1]
Synopsis
As the pandemic gripped the world, global vaccine makers led the battle against the virus. For Indian firms, it was only the beginning of a volley of challenges. Even as they managed to dole out millions of jabs, allegations flew thick and fast. However, with the cloud of uncertainty disappearing, they seem all set to make a big splash.
“First they ignore you. Then they ridicule you. And then they attack you and want to burn you. And then they build monuments to you.”— Nicholas Klein. The American labour union advocate’s inspiring words in a 1918 address to the Amalgamated Clothing Workers in Baltimore, often misattributed to Mahatma Gandhi, have an uncanny relevance in today’s world. For Indian vaccine makers, Serum Institute of India and Bharat Biotech, the last 21 months
- FONT SIZE
AbcSmall
AbcMedium
AbcLarge
Sign in to read the full article
You’ve got this Prime Story as a Free Gift
₹399/month
Monthly
PLAN
Billed Amount ₹399
₹208/month
(Save 49%)
Yearly
PLAN
Billed Amount ₹2,499
15
Days Trial
+Includes DocuBay and TimesPrime Membership.
₹150/month
(Save 63%)
2-Year
PLAN
Billed Amount ₹3,599
15
Days Trial
+Includes DocuBay and TimesPrime Membership.
Already a Member? Sign In now
Get Offer
Why ?
-
Exclusive Economic Times Stories, Editorials & Expert opinion across 20+ sectors
-
Stock analysis. Market Research. Industry Trends on 4000+ Stocks
-
Clean experience with
Minimal Ads -
Comment & Engage with ET Prime community -
Exclusive invites to Virtual Events with Industry Leaders -
A trusted team of Journalists & Analysts who can best filter signal from noise
[ad_2]
Source link